AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating MS and Cancer Treatments
This chapter explores the effects of immune checkpoint inhibitors on multiple sclerosis (MS) patients receiving cancer treatment. It highlights findings from a study of 18 patients, revealing a low risk of relapse and the importance of tailored approaches in managing therapies. The discussion emphasizes the need for collaboration between neurologists and oncologists to optimize patient care while navigating the complexities of both conditions.